Figure 6
Figure 6. Structure of VB22B sc(Fv)2 minibody. A noncovalent (55 kDa) “diabody” (middle of figure) can be generated by taking the VH and VL regions of a whole anti-Mpl monoclonal IgG (left) and coupling them via a 5-amino acid linker (GGGGS). VB22B sc(Fv)2 is made by binding one VH and one VL fragment together with a 15-amino acid linker [(GGGGS)3] and then binding 2 of these constructs together with the same 15-amino acid linker (middle). Both the diabody and the VB22Bsc(Fv)2 bind and activate the TPO receptor (right). Illustration by Paulette Dennis.

Structure of VB22B sc(Fv)2 minibody. A noncovalent (55 kDa) “diabody” (middle of figure) can be generated by taking the VH and VL regions of a whole anti-Mpl monoclonal IgG (left) and coupling them via a 5-amino acid linker (GGGGS). VB22B sc(Fv)2 is made by binding one VH and one VL fragment together with a 15-amino acid linker [(GGGGS)3] and then binding 2 of these constructs together with the same 15-amino acid linker (middle). Both the diabody and the VB22Bsc(Fv)2 bind and activate the TPO receptor (right). Illustration by Paulette Dennis.

Close Modal

or Create an Account

Close Modal
Close Modal